resectable pancreatobiliary tumor
Conditions
Interventions
None listed
Sponsors
Natioinal cancer center hospital
Yokohama City Minato Red Cross Hospital University of Tsukuba Hospital Tane General Hospital Showa Medical University Koto Toyosu Hospital Fukuoka University Hospital Yokohama City University Hospital University of the Ryukyus Hospital Kobe University Hospital Dokkyo Medical University Saitama Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Other imaging studies, including contrast-enhanced CT, performed within 28 days prior to the date of study. Resectable pancreatobiliary tumor by contrast-enhanced CT diagnosis. Age: 18 years or older. PS(ECOG):0,1,2. If the patient is taking antithrombotic medication, it can be discontinued according to the criteria. No bleeding tendency. No gastrointestinal stricture on imaging studies. No massive ascites extending from the liver to the pelvis. Written consent for participation in the study has been obtained from the patient.
Exclusion criteria
Exclusion criteria: Patients with active double cancer. Patients deemed by the physician to be ineligible for enrollment in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic ability of EUS-TA in puncture cases (sensitivity, specificity, positive predictive value, negative predictive value, and accuracy) Comparison of accuracy between contrast-enhanced CT and EUS-TA | — |
Secondary
| Measure | Time frame |
|---|---|
| Technical success rate Comparison of diagnostic ability including difficult puncture cases Diagnostic ability of puncture cases in surgical cases Proportion of patients for whom EUS-TA contributed to treatment decisions Comparison of diagnostic ability of EUS findings Adverse event | — |
Countries
Japan
Contacts
Public ContactHidenobu Hara
Natioinal cancer center hospital Department of hepatobiliary and pancreatic oncology
Outcome results
None listed